Biotech Acquisition (OTCMKTS:BIOTU) Shares Down 7.7%

Biotech Acquisition (OTCMKTS:BIOTU) traded down 7.7% during mid-day trading on Friday . The company traded as low as $10.14 and last traded at $10.14. 1,300 shares were traded during trading, a decline of 71% from the average session volume of 4,444 shares. The stock had previously closed at $10.98.

Biotech Acquisition Stock Performance

The stock has a 50-day moving average price of $10.14 and a 200-day moving average price of $10.14.

Hedge Funds Weigh In On Biotech Acquisition

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Ancora Advisors LLC acquired a new stake in Biotech Acquisition in the first quarter worth approximately $100,000. Virtu Financial LLC acquired a new stake in Biotech Acquisition in the fourth quarter worth approximately $130,000. Finally, Walleye Capital LLC lifted its position in Biotech Acquisition by 51.2% in the first quarter. Walleye Capital LLC now owns 37,192 shares of the company’s stock worth $369,000 after purchasing an additional 12,593 shares during the period.

Biotech Acquisition Company Profile

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.